Indication
Perennial allergic rhinitis
Perennial allergic rhinitis is a chronic, non-seasonal inflammatory disorder of the nasal mucosa triggered by continuous or year-round exposure to indoor aeroallergens, such as house dust mites, animal dander, mold spores, and cockroach antigens. Read more about Perennial allergic rhinitis
607 drugs 168 manufacturers
Drugs that treat it
Common Perennial allergic rhinitis therapies.
BROVEX PD (pseudoephedrine tannate/brompheniramine tannate)
BROVEX ADT (brompheniramine tannate/phenylephrine tannate)
WAL-DRYL-D ALLERY & SINUS (phenylephrine HCl/diphenhydramine HCl)
WAL-PHED PE SINUS-ALLERGY (chlorpheniramine maleate/phenylephrine HCl)
ALA-HIST LQ (phenylephrine HCl/diphenhydramine HCl)
WAL-ACT D COLD & ALLERGY (triprolidine HCl/pseudoephedrine HCl)
ALLERGY RELIEF (cetirizine HCl)
ALL DAY ALLERGY-D (cetirizine HCl/pseudoephedrine HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPerennial allergic rhinitis is a chronic, non-seasonal inflammatory disorder of the nasal mucosa triggered by continuous or year-round exposure to indoor aeroallergens, such as house dust mites, animal dander, mold spores, and cockroach antigens.
It affects both pediatric and adult populations, frequently coexisting with other atopic conditions like asthma and atopic dermatitis.
Pathophysiologically, the condition is driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, leading to mast cell and basophil activation followed by eosinophilic infiltration and cytokine release.
Clinically, it is characterized by persistent nasal congestion, rhinorrhea, nasal pruritus, postnasal drip, and sneezing occurring for an hour or more on most days throughout the year.
- nih.gov
Perennial allergic rhinitis is a chronic, non-seasonal inflammatory disorder of the nasal mucosa triggered by continuous or year-round exposure to indoor aeroallergens, such as house dust mites, animal dander, mold spores, and cockroach antigens Pathophysiologically, the condition is driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, leading to mast cell and basophil activation followed by eosinophilic infiltration and cytokine release
- fda.gov
Perennial allergic rhinitis is a chronic, non-seasonal inflammatory disorder of the nasal mucosa triggered by continuous or year-round exposure to indoor aeroallergens, such as house dust mites, animal dander, mold spores, and cockroach antigens It affects both pediatric and adult populations, frequently coexisting with other atopic conditions like asthma and atopic dermatitis
- nih.gov
It affects both pediatric and adult populations, frequently coexisting with other atopic conditions like asthma and atopic dermatitis Clinically, it is characterized by persistent nasal congestion, rhinorrhea, nasal pruritus, postnasal drip, and sneezing occurring for an hour or more on most days throughout the year
- nih.gov
Pathophysiologically, the condition is driven by an immunoglobulin E (IgE)–mediated type I hypersensitivity reaction, leading to mast cell and basophil activation followed by eosinophilic infiltration and cytokine release
- nih.gov
Clinically, it is characterized by persistent nasal congestion, rhinorrhea, nasal pruritus, postnasal drip, and sneezing occurring for an hour or more on most days throughout the year
Personalize your experience
Follow Perennial allergic rhinitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.